Welcome to The Visible Embryo
The Visible Embryo Home
Home--- -History-----Bibliography-----Pregnancy Timeline-----Prescription Drugs in Pregnancy---- Pregnancy Calculator----Female Reproductive System----News----Contact
WHO International Clinical Trials Registry Platform

The World Health Organization (WHO) has a Web site to help researchers, doctors and patients obtain information on clinical trials.

Now you can search all such registers to identify clinical trial research around the world!




Pregnancy Timeline

Prescription Drug Effects on Pregnancy

Pregnancy Calculator

Female Reproductive System


Disclaimer: The Visible Embryo web site is provided for your general information only. The information contained on this site should not be treated as a substitute for medical, legal or other professional advice. Neither is The Visible Embryo responsible or liable for the contents of any websites of third parties which are listed on this site.

Content protected under a Creative Commons License.
No dirivative works may be made or used for commercial purposes.


Pregnancy Timeline by SemestersDevelopmental TimelineFertilizationFirst TrimesterSecond TrimesterThird TrimesterFirst Thin Layer of Skin AppearsEnd of Embryonic PeriodEnd of Embryonic PeriodFemale Reproductive SystemBeginning Cerebral HemispheresA Four Chambered HeartFirst Detectable Brain WavesThe Appearance of SomitesBasic Brain Structure in PlaceHeartbeat can be detectedHeartbeat can be detectedFinger and toe prints appearFinger and toe prints appearFetal sexual organs visibleBrown fat surrounds lymphatic systemBone marrow starts making blood cellsBone marrow starts making blood cellsInner Ear Bones HardenSensory brain waves begin to activateSensory brain waves begin to activateFetal liver is producing blood cellsBrain convolutions beginBrain convolutions beginImmune system beginningWhite fat begins to be madeHead may position into pelvisWhite fat begins to be madePeriod of rapid brain growthFull TermHead may position into pelvisImmune system beginningLungs begin to produce surfactant
CLICK ON weeks 0 - 40 and follow along every 2 weeks of fetal development


Designing switches to control cell fate

Researchers at the University of Wisconsin-Madison have developed a strategy to reprogram cells from one type to another more efficiently than other methods.

The ability to convert cells from one type to another holds great promise for engineering cells and tissues for use in therapy. The new University of Wisconsin at Madison study could help speed research and bring the new technology into the clinic faster.

The approach was published Dec. 5, 2016, in the Proceedings of the National Academy of Sciences (PNAS). Scientists searched a library of artificial molecules that bind to DNA  — transcription factors — in order to find one that switches on genes and converts cells from one type to another.

Natural transcription factors are molecules in each cell that bind to DNA, turning genes on or off. Turning on specific sets of genes must occur before a cell will commit to become a particular cell type. Artificial transcription factors — made in a lab — can tell researchers which molecules best mimic natural cell fate changes.

According to Asuka Eguchi, member of Aseem Ansari's laboratory in the UW-Madison Department of Biochemistry, and lead author: "Our interest in changing cell fate comes from understanding how cells use information in our genomes to make specific cell types. If a patient needs a certain cell type ...we can reprogram their own cells to what they need, rather than rely on donor cells. This allows us to potentially avoids issues with immune response."

Conventional methods for changing cell fate requires a laborious, slow and failure-prone trial-and-error approach. Scientists need to know which combination — out of thousands — might possibly influence a cell's tightly choreographed timeframe in order to reprogram its fate.

The new method uses "libraries" of millions of artificial transcription factors — designed to bypass natural controls — to turn on genes which might be activated for a given cell type.

By exposing their new library of artificial factors to various cells, they could observe if any cell's fate changed. They then revisited changed cells to see which transcription factors were responsible. Wisconsin researchers chose mice fibroblasts, the most common connective tissue cells, to attempt reprogramming them into pluripotent stem cells.

Given the proper cues, pluripotent stem cells can become any type of cell in an animal's body, including humans. Being able to reprogram a cell to become pluripotent, could mean that artificial transcription factors might trigger the right genes to cause a cell to shift from one type to another.

In the process of testing their new tool, researchers discovered three combinations of artificial factors which reprogram a fibroblast into a stem cell. These factors play a role similar to a natural transcription factor — called Oct4.

"In this unbiased approach, we try to basically cast a wide net on the whole genome and let the cell tell us if there are important genes perturbed,"  explains Ansari, also affiliated with UW-Madison's Genome Center of Wisconsin. "It's a way to induce cell fate conversions without having to know what genes might be important because we are able to test so many by using an unbiased library of molecules that can search nearly every corner of the genome."

The reprogramming of fibroblasts into stem cells is well studied. It is known this approach requires significant changes to a cell. Now, with their proof of concept, Wisconsin scientists hope more researchers use their method to discover new genes which drive even more difficult cell fate conversions.

"Generating pluripotent stem cells also helps us avoid having to make embryonic stem cells — which can be controversial. We can also start better investigating direct conversions, which are conversions from one cell type to another without the need to go to the pluripotent stage first — because that can cause problems in some contexts. This tool opens up the doors to research these areas more effectively."

Asuka Eguchi PhD, Aseem Ansari laboratory, Department of Cellular and Molecular Biology Training Program, Univeristy of Washington, Madison, Wisconsin, USA, and lead author.

The ability to convert cells into desired cell types enables tissue engineering, disease modeling, and regenerative medicine; however, methods to generate desired cell types remain difficult, uncertain, and laborious. We developed a strategy to screen gene regulatory elements on a genome scale to discover paths that trigger cell fate changes. The proteins used in this study cooperatively bind DNA and activate genes in a synergistic manner. Subsequent identification of transcriptional networks does not depend on prior knowledge of specific regulators important in the biological system being tested. This powerful forward genetic approach enables direct cell state conversions as well as other challenging manipulations of cell fate.

Artificial transcription factors (ATFs) are precision-tailored molecules designed to bind DNA and regulate transcription in a preprogrammed manner. Libraries of ATFs enable the high-throughput screening of gene networks that trigger cell fate decisions or phenotypic changes. We developed a genome-scale library of ATFs that display an engineered interaction domain (ID) to enable cooperative assembly and synergistic gene expression at targeted sites. We used this ATF library to screen for key regulators of the pluripotency network and discovered three combinations of ATFs capable of inducing pluripotency without exogenous expression of Oct4 (POU domain, class 5, TF 1). Cognate site identification, global transcriptional profiling, and identification of ATF binding sites reveal that the ATFs do not directly target Oct4; instead, they target distinct nodes that converge to stimulate the endogenous pluripotency network. This forward genetic approach enables cell type conversions without a priori knowledge of potential key regulators and reveals unanticipated gene network dynamics that drive cell fate choices.

Keywords: artificial transcription factor genome-scale library cell fate reprogramming gene regulatory networks

The W.M. Keck Foundation provided funding for the study, as did the National Institutes of Health's Progenitor Cell Biology Consortium. The NIH consortium brought together leading researchers from different scientific disciplines across campus as well as from the University of Minnesota and across the country.
Return to top of page

Dec 14, 2016   Fetal Timeline   Maternal Timeline   News   News Archive   

Induced pluripotent stem cells generated from laboratoty made transcription factors
(made of molecules found in every cell — that bind DNA and turn genes on or off).
These cells express green fluorescent protein after activation of the key gene — Oct4 .

Image Credit:
Asuka Eguchi, University of Wisconsin-Madison



Phospholid by Wikipedia